Abivax SA
NASDAQ:ABVX

  • LAST PRICE
    15.7800
  • TODAY'S CHANGE (%)
    0.0400 (0.2541%)
  • Bid / Lots
    6.3700/ 2
  • Ask / Lots
    25.4700/ 2
  • Open / Previous Close
    15.7800 / 15.7400
  • Day Range
    15.0600
    16.0000
  • 52 Week Range
    7.9950
    17.0200
  • Volume
    53,914

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Recent News

No documents available
0 New Today

Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ABVX
Abivax SA
---
0.0x
---
As of 2024-04-28

Company Information

Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.

Contact Information

Headquarters
7-11 Boulevard HaussmannPARIS, France 75009
Phone
---
Fax
---

Executives

Interim Chairman of the Board, Chief Executive Officer
Marc De Garidel
Interim Independent Chairman of the Board
Corinna Bonsen-Thomas
Chief Financial Officer
Didier Blondel
Chief Human Resource Officer
Ida Hatoum
Vice President - Process Development and Manufacturing
Jerome Denis

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
---
Revenue (TTM)
---
Shares Outstanding
---
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
---
Book Value
---
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.